Suppr超能文献

一项关于炎症标志物在大血管性卒中血管内治疗后无效再通中的预后作用的回顾性观察研究。

A retrospective observational study on the prognostic role of inflammatory markers in futile recanalization after endovascular treatment for large-vessel stroke.

作者信息

Xu Zubing, Guo Linghong, Chen Yunqing, Chen Dandan, Zhang Hudie, Xiong Xilin, Gong Yan, Yu Qiulong, Zeng Chenying, Zhang Lanjiao, Huang Qin, Zhang Jinchong, Zou Keji, Fang Pu, Hong Daojun, Lin Jing, Liu Xian, Li Xiaobing

机构信息

Department of Neurology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.

Institute of Neurology, Jiangxi Academy of Clinical Medical Science, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.

出版信息

J Int Med Res. 2025 Jul;53(7):3000605251359474. doi: 10.1177/03000605251359474. Epub 2025 Jul 30.

Abstract

ObjectiveEndovascular treatment has proven to be effective in improving the outcome of patients with large-vessel stroke. However, more than half of the patients experience poor outcomes despite successful recanalization, which was defined as futile recanalization. The present study aimed to identify the relationship between multiple inflammatory markers (before and after endovascular treatment) and futile recanalization.MethodsBetween November 2019 and September 2022, we retrospectively enrolled 456 patients according to the inclusion and exclusion criteria. Inflammatory variables, including neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, systemic coagulation-inflammation index, and white blood cell count to mean platelet volume ratio, were collected.ResultsAmong the cohort of 456 patients, it was observed that 271 (59.4%) patients experienced futile recanalization. Univariate analysis revealed that patients with futile recanalization had higher neutrophil-to-lymphocyte ratio and systemic inflammatory response index but lower lymphocyte-to-monocyte ratio and systemic coagulation-inflammation index at admission compared with those without (p < 0.05). Additionally, at postoperation, patients with futile recanalization had higher neutrophil-to-lymphocyte ratio, systemic inflammatory response index, and systemic immune-inflammation index but lower lymphocyte-to-monocyte ratio and systemic coagulation-inflammation index compared with those without (p < 0.05). However, there were no significant differences in admission platelet-to-lymphocyte ratio, admission systemic immune-inflammation index, admission white blood cell count to mean platelet volume ratio, postoperation platelet-to-lymphocyte ratio, and postoperation white blood cell count to mean platelet volume ratio between the futile recanalization group and nonfutile recanalization group (p > 0.05). Furthermore, multivariate logistic regression analysis showed that only admission systemic inflammatory response index, postoperation neutrophil-to-lymphocyte ratio, postoperation systemic inflammatory response index, and postoperation systemic immune-inflammation index remained significantly correlated with futile recanalization (p < 0.05). Receiver operating characteristic curves revealed that postoperation neutrophil-to-lymphocyte ratio was the most predictive marker for futile recanalization (area under the curve = 0.623, 95% confidence interval: 0.572-0.675).ConclusionAdmission systemic inflammatory response index, postoperation neutrophil-to-lymphocyte ratio, postoperation systemic inflammatory response index, and postoperation systemic immune-inflammation index were independently associated with futile recanalization, and postoperation neutrophil-to-lymphocyte ratio may have the highest ability in predicting futile recanalization in patients who underwent endovascular treatment.

摘要

目的

血管内治疗已被证明对改善大血管卒中患者的预后有效。然而,超过一半的患者尽管成功再通,但预后仍较差,这被定义为无效再通。本研究旨在确定多种炎症标志物(血管内治疗前后)与无效再通之间的关系。

方法

2019年11月至2022年9月,我们根据纳入和排除标准回顾性纳入了456例患者。收集炎症变量,包括中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值、全身免疫炎症指数、全身炎症反应指数、全身凝血炎症指数以及白细胞计数与平均血小板体积比值。

结果

在456例患者队列中,观察到271例(59.4%)患者出现无效再通。单因素分析显示,与未出现无效再通的患者相比,出现无效再通的患者入院时中性粒细胞与淋巴细胞比值和全身炎症反应指数较高,但淋巴细胞与单核细胞比值和全身凝血炎症指数较低(p<0.05)。此外,术后与未出现无效再通的患者相比,出现无效再通的患者中性粒细胞与淋巴细胞比值、全身炎症反应指数和全身免疫炎症指数较高,但淋巴细胞与单核细胞比值和全身凝血炎症指数较低(p<0.05)。然而,无效再通组与非无效再通组在入院时血小板与淋巴细胞比值、入院时全身免疫炎症指数、入院时白细胞计数与平均血小板体积比值、术后血小板与淋巴细胞比值以及术后白细胞计数与平均血小板体积比值方面无显著差异(p>0.05)。此外,多因素logistic回归分析显示,仅入院时全身炎症反应指数、术后中性粒细胞与淋巴细胞比值、术后全身炎症反应指数以及术后全身免疫炎症指数与无效再通仍显著相关(p<0.05)。受试者工作特征曲线显示,术后中性粒细胞与淋巴细胞比值是无效再通最具预测性的标志物(曲线下面积=0.623,95%置信区间:0.572-0.675)。

结论

入院时全身炎症反应指数、术后中性粒细胞与淋巴细胞比值、术后全身炎症反应指数以及术后全身免疫炎症指数与无效再通独立相关,且术后中性粒细胞与淋巴细胞比值在预测接受血管内治疗患者的无效再通方面可能具有最高能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64ec/12317200/242feca4d732/10.1177_03000605251359474-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验